THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Recruiting
Phase 4Interventional Study
Venous ThromboembolismVaricose Veins
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Prevention
Participants needed
3,175 (estimated)
Sponsor
Imperial College London · Other
Who this trial is looking for
This trial is looking for adults who are scheduled to have a specific procedure for varicose veins. Participants will find out if taking medicine to prevent blood clots after the treatment is helpful.
Are You a Good Fit for This Trial?
You may be able to join if
I am an adult over 18 years old
I am scheduled for an endovenous treatment for varicose veins
I will receive local anesthesia for the procedure
The treatment method includes radiofrequency, laser, foam sclerotherapy, or cyanoacrylate glue
You may not be able to join if
I have a condition that requires blood-thinning medication
I have a personal or family history of blood clots
I have a condition that makes me prone to blood clots
I am a female who could become pregnant and have a positive pregnancy test
I am allergic to heparin or blood thinners
I have had heparin-induced thrombocytopenia
I have bleeding disorders or active bleeding
I have serious health problems like active cancer or severe kidney/liver issues
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Endovenous interventions are keyhole operations for varicose veins that are carried out from within the vein itself. Varicose veins are enlarged veins close to the surface of the skin. They are connected to the bigger deeper veins in the leg (known as deep veins). Because of this, operations to close the varicose veins can increase the chance of a blood clot forming in the deep veins. Blood clots …
Endovenous interventions are keyhole operations for varicose veins that are carried out from within the vein itself. Varicose veins are enlarged veins close to the surface of the skin. They are connected to the bigger deeper veins in the leg (known as deep veins). Because of this, operations to close the varicose veins can increase the chance of a blood clot forming in the deep veins. Blood clots in the deep veins happen in around 1 in 50 people after endovenous operations. A clot in the leg can cause swelling, pain, and other long-term problems. If a clot in the leg breaks off and travels to the lungs, it can cause problems with the lung' ability to move oxygen from the air into the blood and may, in rare cases, be life threatening.
Varicose vein procedures may carry a slightly higher risk of blood clot formation, and we are currently unsure if current clot reducing medicines are beneficial in preventing blood clots in people having varicose vein procedures.
This study will investigate if it is worthwhile prescribing medicines to reduce blood clots after varicose vein procedures.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Adults (\>18 years)
* Scheduled to undergo endovenous intervention of truncal varicose veins under local anaesthesia
* Treatment technologies including radiofrequency, laser, mechanochemical, foam sclerotherapy and cyanoacrylate glue
Exclusion Criteria:
* Clinical indication…
Inclusion Criteria:
* Adults (\>18 years)
* Scheduled to undergo endovenous intervention of truncal varicose veins under local anaesthesia
* Treatment technologies including radiofrequency, laser, mechanochemical, foam sclerotherapy and cyanoacrylate glue
Exclusion Criteria:
* Clinical indication for therapeutic anticoagulation e.g., atrial fibrillation
* Previous personal or first-degree relative history of VTE
* Thrombophilia
* Female patients of childbearing potential who have a positive pregnancy test
* A history of allergy to heparins or direct oral anticoagulants
* A history of heparin-induced thrombocytopenia
* Inherited and acquired bleeding disorders
* Evidence of active bleeding
* Concomitant major health problems such as active cancer and chronic renal and/or liver impairment
* Known thrombocytopenia (platelets known to be less than 50 x 109
/l)
* Surgery or major trauma in the previous 90 days
* Recent ischemic stroke in the previous 90 days
* Inability to provide consent
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.